Unpacking the Latest Options Trading Trends in Viking Therapeutics
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $12.0 to $100.0 for Viking Therapeutics over the last 3 months. Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
深口袋的投資者對Viking Therapeutics（NASDAQ:VKTX）採取了看淡的態度，這是市場參與者不應忽視的事情。我們在Benzinga的公共期權記錄跟蹤中發現了這個重要的動向。這些投資者的身份尚不清楚，但VKTX的這樣巨大的變動通常意味着即將發生一些重要的事情。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
今天Benzinga的期權掃描儀突出了Viking Therapeutics 的17種非凡期權活動，我們通過今天的觀察獲得了這些信息。這種活動水平是不尋常的。
The general mood among these heavyweight investors is divided, with 29% leaning bullish and 52% bearish. Among these notable options, 2 are puts, totaling $76,575, and 15 are calls, amounting to $585,344.
這些重量級投資者的心情普遍分爲兩種，29%看好，52%看淡。在這些值得注意的期權中，有2個是看跌期權，總計76,575美元，還有15個看漲期權，總計585,344美元。
Projected Price Targets
預計價格目標
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $12.0 to $100.0 for Viking Therapeutics over the last 3 months.
考慮到這些合約的成交量和未平倉利息，似乎在過去的三個月中鯨魚們一直在瞄準Viking Therapeutics的股價區間爲12到100美元。
Volume & Open Interest Trends
成交量和未平倉量趨勢
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price.
下面，我們可以觀察到在Viking Therapeutics 49.0美元至130.0美元行權價位範圍內，鯨魚對看漲期權和看跌期權的成交量和持倉量的演變情況。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale activity within a strike price range from $12.0 to $100.0 in the last 30 days.
下面我們可以看到，在過去30天中，Viking Therapeutics所有的鯨魚活動中，所有期權的成交量和未平倉利息的演變情況，其中包括了所有在12到100美元的執行價格區間內的看漲期權和看跌期權。
Viking Therapeutics Option Activity Analysis: Last 30 Days
Viking Therapeutics 期權交易分析：過去30天
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 11/15/24 | $19.3 | $18.3 | $18.5 | $50.00 | $62.9K | 299 | 11 |
| VKTX | CALL | SWEEP | BEARISH | 08/30/24 | $3.2 | $2.8 | $2.8 | $70.00 | $54.6K | 245 | 402 |
| VKTX | CALL | TRADE | BEARISH | 01/17/25 | $51.8 | $51.0 | $51.0 | $12.00 | $51.0K | 70 | 10 |
| VKTX | PUT | TRADE | BEARISH | 09/20/24 | $8.3 | $7.2 | $8.3 | $65.00 | $49.8K | 544 | 0 |
| VKTX | CALL | SWEEP | BEARISH | 08/30/24 | $3.2 | $3.0 | $3.0 | $65.00 | $45.0K | 1.5K | 477 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看漲 | 交易 | 看淡 | 11/15/24 | $19.3 | $18.3 | $18.5 | $50.00 | $62.9K | 299 | 11 |
| VKTX | 看漲 | SWEEP | 看淡 | 08/30/2024 | $3.2 | $2.8 | $2.8 | 70.00美元 | $54.6K | 245 | 402 |
| VKTX | 看漲 | 交易 | 看淡 | 01/17/25 | $51.8 | $51.0 | $51.0 | 12.00美元 | $51.0K | 70 | 10 |
| VKTX | 看跌 | 交易 | 看淡 | 09/20/24 | $8.3 | $7.2 | $8.3 | $65.00 | $49.8K | 544 | 0 |
| VKTX | 看漲 | SWEEP | 看淡 | 08/30/2024 | $3.2 | $3.0 | $3.0 | $65.00 | $45.0K | 1.5K | 477 |
About Viking Therapeutics
關於Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家衛生服務提供商，專門從事代謝和內分泌障礙領域的生物製藥開發。該公司的臨床項目流水線包括VK2809、VK5211、VK0214產品。VK2809和VK0214是口服、組織和受體亞型選擇性的甲狀腺激素受體β激動劑。VK5211是一種口服、非類固醇選擇性雄激素受體調節劑。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析與Viking Therapeutics相關的期權交易活動後，我們轉而更近距離地關注該公司的業績表現。
Viking Therapeutics's Current Market Status
維京治療公司的當前市場狀態
- Currently trading with a volume of 2,237,127, the VKTX's price is down by -5.93%, now at $62.68.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 64 days.
- VKTX當前的成交量爲2,237,127，價格下跌了5.93%，現在爲62.68美元。
- RSI讀數表明該股目前可能接近超買水平。
- 預計即將發佈的業績還有64天。
Expert Opinions on Viking Therapeutics
維京治療公司的專家意見
In the last month, 2 experts released ratings on this stock with an average target price of $104.0.
在過去一個月中，另外兩位專家發佈了關於這個股票的評級，目標價的平均值爲104.0美元。
- An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $90.
- An analyst from Raymond James persists with their Strong Buy rating on Viking Therapeutics, maintaining a target price of $118.
- 來自HC Wainwright & Co.的分析師已將評級調低爲買入，調整價格目標爲90美元。
- 來自Raymond James的分析師堅持他們對Viking Therapeutics的強烈買入評級，維持目標價爲118美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Viking Therapeutics options trades with real-time alerts from Benzinga Pro.
期權交易具有更高的風險和潛在回報。精明的交易者通過不斷學習，調整策略，監測多種因子以及密切關注市場走勢來管理這些風險。通過Benzinga Pro的實時警報隨時了解最新的Viking Therapeutics期權交易。
